New European Leadership Backpedals: EU Device Oversight Will Stay In Health Division
This article was originally published in The Gray Sheet
The incoming president of the European Commission has reversed a decision that would have moved EU oversight of medical device and drug policy issues from the health division to the markets/industry division following criticism from lawmakers and health care advocates.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.